Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Terminating a long-term clinical trial

C R Klimt

    Controlled Clinical Trials
    |May 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Managing long-term clinical trials involves understanding various termination reasons. This includes stopping ineffective treatments, excluding non-responsive patient subgroups, and adapting to therapeutic breakthroughs or abandoned treatment hopes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Emergency department duty: a training model for the future.

    Military medicine·1991
    Same author

    Varied acceptance of clinical trial results.

    Controlled clinical trials·1989
    Same author

    Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin.

    Journal of the American College of Cardiology·1986
    Same author

    The Coronary Drug Project. Experimental design features.

    Controlled clinical trials·1983
    Same author

    A transcribed emergency record at minimum cost.

    Annals of emergency medicine·1983
    Same author

    Secondary prevention of myocardial infarction with drugs.

    Israel journal of medical sciences·1983
    Same journal

    On the generation and ownership of alpha in medical studies.

    Controlled clinical trials·2004
    Same journal

    An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia.

    Controlled clinical trials·2004
    Same journal

    Symptom recording in a randomised clinical trial: paper diaries vs. electronic or telephone data capture.

    Controlled clinical trials·2004
    Same journal

    Statistical comparison of random allocation methods in cancer clinical trials.

    Controlled clinical trials·2004
    Same journal

    Analyzing bronchodilation with emphasis on disease type, age and sex.

    Controlled clinical trials·2004
    Same journal

    Geographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in acute myocardial infarction.

    Controlled clinical trials·2004
    See all related articles

    Area of Science:

    • Clinical research methodology
    • Pharmaceutical development
    • Biostatistics

    Background:

    • Long-term clinical trials frequently involve multiple active treatment arms.
    • Independent discontinuation of treatment groups is common due to inefficacy or safety concerns.
    • Patient subgroup identification and exclusion can occur during trials.

    Purpose of the Study:

    • To explore diverse termination scenarios in long-term clinical trials.
    • To present practical examples of managing trial terminations.
    • To discuss successful and unsuccessful termination management techniques.

    Main Methods:

    • Review of clinical trial termination protocols.
    • Case study analysis of author experiences.
    • Qualitative assessment of management strategies.

    Related Experiment Videos

    Main Results:

    • Common termination triggers include inefficacy, harm, patient non-response, therapeutic breakthroughs, and abandonment of hope.
    • Effective management of terminations requires adaptive strategies.
    • Both successful and unsuccessful techniques were observed in practice.

    Conclusions:

    • Clinical trial terminations are multifaceted and require careful, adaptive management.
    • Learning from diverse termination experiences can improve future trial conduct.
    • Strategic handling of trial endpoints is crucial for valid scientific outcomes.